EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CMPK2 restricts Zika virus replication by inhibiting viral translation

Joanna B Pawlak, Jack Chun-Chieh Hsu, Hongjie Xia, Patrick Han, Hee-Won Suh, Tyler L Grove, Juliet Morrison, Pei-Yong Shi, Peter Cresswell, Maudry Laurent-Rolle iD

PLOS Pathogens · 19.04.2023 · 19 (4) · e1011286

DOI: 10.1371/journal.ppat.1011286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 19.04.2023. Verfasst von Joanna B Pawlak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America. Hauptthemen laut MEDLINE: Virus Replication, Zika Virus, Nucleoside-Phosphate Kinase. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flaviviruses continue to emerge as global health threats. There are currently no Food and Drug Administration (FDA) approved antiviral treatments for flaviviral infections. Therefore, there is a pressing need to identify host and viral factors that can be targeted for effective therapeutic intervention. Type I interferon (IFN-I) production in response to microbial products is one of the host’s first line of defense against invading pathogens. Cytidine/uridine monophosphate kinase 2 (CMPK2) is a type I interferon-stimulated gene (ISG) that exerts antiviral effects. However, the molecular mechanism by which CMPK2 inhibits viral replication is unclear. Here, we report that CMPK2 expression restricts Zika virus (ZIKV) replication by specifically inhibiting viral translation and that IFN-I- induced CMPK2 contributes significantly to the overall antiviral response against ZIKV. We demonstrate that expression of CMPK2 results in a significant decrease in the replication of other pathogenic flaviviruses including dengue virus (DENV-2), Kunjin virus (KUNV) and yellow fever virus (YFV). Importantly, we determine that the N-terminal domain (NTD) of CMPK2, which lacks kinase activity, is sufficient to restrict viral translation. Thus, its kinase function is not required for CMPK2’s antiviral activity. Furthermore, we identify seven conserved cysteine residues within the NTD as critical for CMPK2 antiviral activity. Thus, these residues may form an unknown functional site in the NTD of CMPK2 contributing to its antiviral function. Finally, we show that mitochondrial localization of CMPK2 is required for its antiviral effects. Given its broad antiviral activity against flaviviruses, CMPK2 is a promising potential pan-flavivirus inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus ReplicationZika VirusNucleoside-Phosphate KinaseVero CellsChlorocebus aethiopsAnimalsHumansInterferon Type IFlavivirusMitochondriaProtein Biosynthesis

Substanzen

CMPK2 protein, humanNucleoside-Phosphate KinaseInterferon Type I

Autor:innen und Institutionen

  • Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Department of Biomedical Engineering, Yale University School of Engineering and Applied Science, New Haven, Connecticut, United States of America.

ORCID-Profile: Maudry Laurent-Rolle

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • NHLBI NIH HHS
  • National institute of haematology and blood transfusion
  • Cancer Research Institute
  • Transimmune AG
  • Searle Scholars Program
  • Sealy and Smith Foundation

Zitieren

APA

Pawlak, J. B., Hsu, J. C., Xia, H., Han, P., Suh, H. W., Grove, T. L., Morrison, J., Shi, P. Y., Cresswell, P., & Laurent-Rolle, M. (2023). CMPK2 restricts Zika virus replication by inhibiting viral translation. PLOS Pathogens, 19(4), e1011286. https://doi.org/10.1371/journal.ppat.1011286

Vancouver

Pawlak JB, Hsu JC, Xia H, Han P, Suh HW, Grove TL, et al. CMPK2 restricts Zika virus replication by inhibiting viral translation. PLOS Pathogens. 2023;19(4):e1011286. doi:10.1371/journal.ppat.1011286

BibTeX
@article{Pawlak2023,
  author = {Pawlak, Joanna B and Hsu, Jack Chun-Chieh and Xia, Hongjie and Han, Patrick and Suh, Hee-Won and Grove, Tyler L and Morrison, Juliet and Shi, Pei-Yong and Cresswell, Peter and Laurent-Rolle, Maudry},
  title = {CMPK2 restricts Zika virus replication by inhibiting viral translation},
  journal = {PLOS Pathogens},
  year = {2023},
  volume = {19},
  number = {4},
  pages = {e1011286},
  doi = {10.1371/journal.ppat.1011286}
}
Kostenlos starten →